Navigation Links
Risk of stroke doubles if diagnosed with Type 2 diabetes

Individuals diagnosed with Type 2 diabetes are at double the risk of having a stroke compared to those without diabetes, according to new research from the University of Alberta. It was found that the risk of a stroke is considered high within the first five years of treatment for Type 2 diabetes and more than doubles the rate of occurrence.

For this study, the researchers entered 12,272 subjects into a Type 2 diabetes cohort. All subjects were recently diagnosed with Type 2 diabetes and had a mean age of 64 years. After five years of monitoring, stroke incidence rates were compared between the cohort and the general population.

“What we found is that 9.1 per cent of the diabetes cohort had a stroke within the first five years of their diagnosis,” Dr. Thomas Jeerakathil, an assistant professor in neurology, at the University of Alberta. “We also found that compared to persons from the general population of a similar age, the relative risk for stroke was much greater in younger persons with diabetes than for older persons.

As it has been more common to study stroke prevalence within 10 years after diagnosis, this is the first study to specifically examine stroke-related outcomes immediately after the diagnosis of and initiation of treatment for Type 2 diabetes.

Jeerakathil indicates it is possible that physicians are undertreating stroke risks because of a prevailing attitude among physicians and patients that the cardiovascular complications of diabetes occur long after diagnosis rather than in the first five years.

“We hope our findings will help to dispel the notion that the risk of stroke occurs only in the long term and will improve the motivation of both patients and health care providers to aggressively control cardiovascular risk factors soon after diagnosis.” said Jeerakathil.


'"/>

Source:University of Alberta


Page: 1

Related biology news :

1. Researchers discover molecule that causes secondary stroke
2. Molecular cabal contributes to stroke damage
3. Blocking the nerve receptor EP1 in mouse models reduces brain damage caused by stroke
4. Limiting the damage in stroke
5. Cord blood cells may widen treatment window for stroke
6. Bad enzymes may wear white hats after stroke
7. Stem cell transplants improve recovery in animal models for stroke, cerebral palsy
8. Internal body clock dictates timing of different types of stroke
9. New compound reduces stroke damage
10. Acidity in the brain could hold the key to stroke treatment
11. UBC researchers find stroke death channel
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
Breaking Biology News(10 mins):
(Date:4/29/2016)... ... 29, 2016 , ... Summit for Stem Cell has received a $250,000 grant ... stem cell therapy for the treatment of Parkinson’s disease. The Summit research project is ... Scripps Research Institute in San Diego, CA. , The aim of of ...
(Date:4/28/2016)... Hill, Conn. (PRWEB) , ... April 28, 2016 ... ... of financing and ongoing support for Connecticut's innovative, growing companies, today announced the ... digital health and financial technology (fintech) companies. , “VentureClash looks to ...
(Date:4/27/2016)... ... 2016 , ... Shimadzu Scientific Instruments (SSI) will be showcasing ... Conference and Expo. Shimadzu’s high-performance instruments enable laboratories to test cannabis products for ... stop by booth 1021 to learn how Shimadzu’s instruments can help improve QA/QC ...
(Date:4/27/2016)... ... 27, 2016 , ... The Board of Directors of Biohaven ... Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from Alexion Pharmaceuticals, Inc. ... responsible for the commercialization of multiple orphan drug indications. Mr. Tilton has ...
Breaking Biology Technology: